Clinical trial PanCO
An open label, single arm pilot study of OncoSilTM, administered to study participants with unresectable locally advanced pancreatic adenocarcinoma, given in combination with FOLFIRINOX or gemcitabine+nab-paclitaxel chemotherapies
| Cancers | |
|---|---|
| Organ | pancreas |
| Trial status | Trial closed |
| Trial type |
Medical devices
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | OncoSil Medical |
| BECT Identifier | B079201732538 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03003078 |
| Inclusion criteria | Target tumour diameter of ? 2.0 cm (shortest axis) |
| Last update |